NCT03271892View on ClinicalTrials.gov

Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 11, 2016

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions
Thyroid Cancer Stage I
Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

collaborator

Ontario Ministry of Health and Long Term Care

OTHER_GOV

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University Health Network, Toronto

OTHER

NCT03271892 - Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer | Biotech Hunter | Biotech Hunter